Greek English Arabic Arabic Romanian Russian
AABB Accredited
Tuesday, 28 March 2017
The first and largest family Umbilical Cord Blood and Tissue Bank in Cyprus.

Quick Search:
Enrol with Lifeline Lifeline Advantages Video Center Contact Lifeline Brochure
About Us
Umbilical Cord Blood
Introduction to UCB
Stem Cells & Haematopoietic Stem Cell Transplants
Current Applications
Advantages and Limitations to Cord Blood Banking
Cord Blood Banking Options
Biology of Blood
Umbilical Cord Tissue
Regenerative Medicine
Lifeline Service
Stem Cell Collection
Laboratory Facilities
Lifeline News
Media and Video News
Regulations & Directives
Contact Us
AABB Accredited
European Business Awards 2014-15
Lifeline, Winner of the Cyprus Innovation Award - Services Sector 2010

Introduction to Umbilical Cord Blood


Video: What are Stem Cells



Umbilical cord blood is the blood that remains in the umbilical cord after a baby is born and the cord is cut. Until recently, this blood as well as the cord and the placenta were treated as clinical waste and were discarded.  Since the discovery that cord blood is a rich source of haematopoietic stem cells and since the first transplant in 1988, this valuable source of stem cells is no longer considered as a clinical waste. Public and family banks were created to process and cryopreserve this blood for future use.


Cord blood contains all the normal elements of blood - red blood cells, white blood cells, platelets and plasma. It is also rich in haematopoietic (blood-forming) stem cells, similar to those found in bone marrow. The Haematopoietic (progenitor) stem cells are situated in the liver and spleen of every embryo. Prior to labour, these cells begin to migrate from the liver through the blood stream towards the bones for the formation of the bone marrow. Collection of cord blood can be performed either at the third stage of labour (after the birth of the baby and before the delivery of the placenta) or ex-utero (after the delivery of the placenta).


Cord blood can be used for transplantation as an alternative to bone marrow cells. Compared with adult peripheral blood or bone marrow, cord blood contains a greater proportion of highly proliferative haematopoietic progenitor cells. Most cord blood transplants have been done to treat diseases of the blood and immune system. It has also been used to restore the functional deficiencies of several genetic metabolic diseases. To date, more than 70 different diseases have been treated with cord blood transplants.


The number of transplantations using umbilical cord cells is rising every year. Since 2005 allogeneic umbilical cord transplants in children outnumber the transplantations of bone marrow cells.

The positive outcomes from cord blood research and applications have lead to new experimental applications for the treatment of other serious conditions. Scientists are investigating the possibility that stem cells in cord blood may be able to replace cells of other tissues such as nerve or heart cells.


Researchers and scientists accept that future therapies will be based on stem cells from various sources including cord blood. Research is ongoing in numerous centres for therapies of currently incurable diseases such as Multiple Sclerosis and Alzheimers'.

Enrol with Lifeline

Featured Videos

Cord Blood News

Stem Cell

Cord Blood News

Cord blood - Could an umbilical cord really save lives?

Cord Blood News

What is cord blood

Cord Blood News

What You Should Know About Cord Blood Banking

Top  |  Back  |  Easy Print  |  Advanced Search  |  Contact Us  |  Home
Participation in External Quality Control Schemes
UK NEQAS International Quality Expertise Labquality AABB Accredited
Lifeline © Copyright © C.B.B. Lifeline Biotech Ltd  |  Disclaimer  |  Terms of Use Design & Development: Crucial Services Ltd